Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The thoracic surgical industrial complex.

A Starr

    The Annals of Thoracic Surgery
    |August 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    The $2 billion thoracic surgical industry faces six forces, balancing innovation against regulation. Growth favors less risky devices, impacting the future of artificial hearts.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Implementation of an automated, real-time mortality prediction tool in trauma patients: Can it do more than just predict mortality?

    Injury·2025
    Same author

    Clinical and radiographic predictors for angiography in pelvic trauma: An analysis of 1703 patients.

    Injury·2024
    Same author

    Publisher Correction: Indo-Pacific Walker circulation drove Pleistocene African aridification.

    Nature·2022
    Same author

    Indo-Pacific Walker circulation drove Pleistocene African aridification.

    Nature·2021
    Same author

    Validating the GTP-cyclohydrolase 1-feedback regulatory complex as a therapeutic target using biophysical and in vivo approaches.

    British journal of pharmacology·2015
    Same author

    CARDIOVASCULAR SURGERY.

    A listing of research in the cardiovascular field·2014
    Same journal

    Context-Driven Management of Bilateral Diaphragmatic Failure After Phrenic Nerve Sacrifice.

    The Annals of thoracic surgery·2026
    Same journal

    Uncomplicated type B aortic dissection: Are US-based societal guidelines delaying science?

    The Annals of thoracic surgery·2026
    Same journal

    Methodological Paradigms and Clinical Realities in Defining High-Volume Centres for Valve-Sparing Aortic Root Replacement.

    The Annals of thoracic surgery·2026
    Same journal

    Long-Term Outcomes of Concomitant Atrial Fibrillation Management During CABG: Standardization or Compromise?

    The Annals of thoracic surgery·2026
    Same journal

    Ongoing Dialogue and Support for the Future of Congenital Cardiac Surgery.

    The Annals of thoracic surgery·2026
    Same journal

    A Bridge With Gaps.

    The Annals of thoracic surgery·2026
    See all related articles

    Area of Science:

    • Thoracic surgery
    • Medical device industry
    • Health economics

    Background:

    • The thoracic surgical industry is a significant economic sector, valued at $2 billion annually.
    • This industry is influenced by a complex interplay of economic, regulatory, and technological factors.
    • Understanding these forces is crucial for analyzing the industry's evolution and future product development.

    Observation:

    • The industry is shaped by three positive forces: technological innovation, entrepreneurial activity, and capital flow.
    • Conversely, three negative forces impede progress: government regulation, cost-containment measures, and high product liability insurance costs.
    • A critical juncture has been reached, with industry growth shifting towards lower-risk non-implantable devices.

    Findings:

    Related Experiment Videos

  • Growth in the thoracic surgical market is currently concentrated in non-implantable devices.
  • High-risk implantable devices, such as the artificial heart, face significant developmental challenges due to the negative forces.
  • The balance of these six forces will determine the pace of development for advanced implantable technologies.

    • Implications:

    • The future development of the artificial heart is contingent upon navigating the complex landscape of industry forces.
    • Strategic adjustments may be needed to foster innovation in high-risk implantable device sectors.
    • Further analysis is required to understand how to best balance these competing forces for technological advancement.